4
Changes in Ownership
Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-22-015033
Options or other derivatives
- Director acquired 23,345 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Billen Daniel Director | 2022-05-18 | Grant or award · Restricted Stock Unit | +8,733 | 8,733 | D | ||
| Billen Daniel Director | 2022-05-18 | Grant or award · Stock Option (right to buy) | +14,612 | 14,612 | D | ||
Loading xslF345X03/wf-form4_165307735548328.xml…